We are live on ! Find out more
NMC

Nine Masts Capital Portfolio holdings

AUM $995M
1-Year Est. Return 22.79%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+22.79%
3 Year Est. Return
+88.15%
5 Year Est. Return
+47.84%
10 Year Est. Return
+90.58%
AUM
$995M
AUM Growth
+$302M
Cap. Flow
+$55.8M
Cap. Flow %
5.61%
Top 10 Hldgs %
72.43%
Holding
311
New
63
Increased
15
Reduced
79
Closed
141

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$299M
2
HDB icon
HDFC Bank
HDB
+$50.2M
3
BCS icon
Barclays
BCS
+$11.9M
4
ROKU icon
Roku
ROKU
+$10.1M
5
KVUE icon
Kenvue
KVUE
+$7.84M

Sector Composition

Rank Sector Weight
1 Miscellaneous 59.5%
2 Financials 14.37%
3 Communication Services 10.05%
4 Technology 4.56%
5 Industrials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAYO icon
151
Payoneer
PAYO
$2.43B
$96.1K 0.01%
+13,493
New +$73.9K
MSFT icon
152
CALL
Microsoft
MSFT
$3.71T
$84.9K 0.01%
+50
New +$20.2K
FITB
153
PUT
Fifth Third Bancorp
FITB
$49.8B
$82.3K 0.01%
700
-45,300
-98% -$2.3M
VOXR
154
Vox Royalty Corp
VOXR
$400M
$79.6K 0.01%
+16,825
New +$92.6K
GROY icon
155
Gold Royalty Corp
GROY
$776M
$76.5K 0.01%
+27,730
New +$91.4K
PDD icon
156
CALL
Pinduoduo
PDD
$117B
$36.2K ﹤0.01%
200
-19,800
-99% -$1.83M
ZS icon
157
Zscaler
ZS
$27.7B
$23.4K ﹤0.01%
+166
New +$23.1K
FUTU icon
158
CALL
Futu Holdings
FUTU
$17.1B
$20.2K ﹤0.01%
43
-4,257
-99% -$545K
XBI icon
159
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.4B
$18.1K ﹤0.01%
+100
New +$13.5K
BHF icon
160
CALL
Brighthouse Financial
BHF
$3.08B
$5.1K ﹤0.01%
+10
New +$622
PRENW
161
Prenetics Global Ltd Warrant
PRENW
$146K
0
SLAB icon
162
CALL
Silicon Laboratories
SLAB
$7.36B
$3.05K ﹤0.01%
+20
New +$4.33K
PFE icon
163
CALL
Pfizer
PFE
$162B
$2.05K ﹤0.01%
100
-68,100
-100% -$1.78M
AIV
164
Aimco
AIV
$372M
-10,836
Closed -$44.1K
ALIT icon
165
Alight
ALIT
$398M
-2,156
Closed -$25.1K
ALT icon
166
Altimmune
ALT
$665M
-11,850
Closed -$36.5K
ALXO icon
167
ALX Oncology
ALXO
$278M
-20,623
Closed -$41.3K
AMT icon
168
CALL
American Tower
AMT
$81.9B
-33,000
Closed -$208K
AMT icon
169
PUT
American Tower
AMT
$81.9B
-50,000
Closed -$770K
AMTX icon
170
Aemetis
AMTX
$132M
-11,110
Closed -$35.4K
APLS
171
DELISTED
Apellis Pharmaceuticals
APLS
-97,478
Closed -$3.92M
ATNM icon
172
Actinium Pharmaceuticals
ATNM
$32.3M
-35,227
Closed -$35.1K
OPTU
173
Optimum Communications Inc
OPTU
$401M
-19,272
Closed -$25.1K
AZN icon
174
AstraZeneca
AZN
$252B
-2,000
Closed -$394K
BDTX icon
175
Black Diamond Therapeutics
BDTX
$122M
-17,806
Closed -$37.9K

Similar funds

Nine Masts Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Nine Masts Capital held 311 positions worth $995M, up 44% from $693M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Nine Masts Capital deployed $55.8M of net new capital in Q2 2026, opening 63 new positions and adding to 15 existing holdings. Its largest new stake was Barclays: 493,965 shares worth $13.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 38% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $82.5M trimmed.

  • Nine Masts Capital's largest Q2 2026 buy was Barclays: 493,965 shares worth $13.3M.
  • Nine Masts Capital added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $299M increase.
  • Nine Masts Capital's biggest Q2 2026 reduction was Alphabet (Google) Class C, cutting an estimated $82.5M.
  • Nine Masts Capital fully exited Invesco QQQ Trust in Q2 2026, selling an estimated $19.1M.
  • Nine Masts Capital's ten largest holdings make up 72% of its $995M portfolio in Q2 2026.
  • Nine Masts Capital opened 63 new positions and closed 141 in Q2 2026.
  • Nine Masts Capital's portfolio value rose 44% quarter-over-quarter to $995M.

Based on Nine Masts Capital's 13F filing for Q2 2026, filed 7 Aug 2026.